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LETTERS TO THE EDITOR
Milking In Hypertrophic Cardiomyopathy
Yetman et al. (1) retrospectively reviewed angiograms performed
over 40-years in children with hypertrophic cardiomyopathy
(HCM). Ten (28%) of 36 children had a myocardial bridge that
was associated with an adverse prognosis. They suggested that
myocardial bridging may cause ischemia and represents a risk
factor for sudden death (1). Clarification of some methodologic
aspects is important, given the potential importance of this finding.
The criteria used to select children for coronary angiography are
unclear. Coronary milking is a dynamic phenomenon. In this
regard, no information was provided on medications at the time of
angiography (e.g., whether intracoronary nitroglycerin was admin-
istered or whether the bridging was visualized after specific
maneuvers to elicit intraventricular gradients) (1,2). Despite severe
myocardial bridging (.90% systolic diameter narrowing, extend-
ing 50 6 17% of the diastolic period), the diagnosis of the
phenomenon was initially made in only three patients (2). In our
experience, ventricular arrhythmias are uncommon in children
with HCM and are usually asymptomatic (3). This is in contrast
with the high incidence of ventricular tachycardia (21 [27%] of 78
patients, 9 of whom were symptomatic) in the present study (1).
Symptomatic sustained ventricular tachycardia is rare in HCM and
has been associated with apical ventricular aneurysms (4). A more
detailed description of the patients with ventricular arrhythmia
seems warranted. The presence of wall motion abnormalities
would further support the hypothesis of myocardial bridging as the
cause of ischemia.
Children with HCM are at greater risk of sudden death, yet risk
stratification is particularly challenging in children (3). There is
debate over the significance of myocardial bridging. Although the
hypothesis of Yetman et al. (1) is attractive, they fail to provide
conclusive evidence that myocardial bridging induced ischemia. In
addition, the exact mechanism leading to ventricular arrhythmias
and sudden death remains elusive. We are concerned by the
potential implications of this study. Should selective coronary
angiography be included in the diagnostic assessment of most
children with HCM, or should it only be reserved for those
requiring more precise risk stratification? We believe that owing to
the high incidence of milking among low risk adult patients with
HCM (2), coronary angiography should only be considered for
children with recognized risk factors (e.g., recurrent syncope,
strong family history of sudden death) or for those with refractory
symptoms. We are also worried by the possibility that coronary
revascularization may now be easily contemplated if a myocardial
bridge is demonstrated. In fact, coronary stenting seems to be a
much more attractive strategy for these children than the classic
surgical “unroofing.” Although initial results of coronary stenting
in this setting seem favorable, a relatively high restenosis rate (or
rather, stent stenosis) has been reported (5). Furthermore, we have
previously demonstrated (6) that coronary stenting itself may
induce the appearance of systolic coronary narrowing at a different
site.
We write not to “fire bullets” at what is a potentially useful
observation, but rather to clarify the context and practical aspects
in relation to the significance of myocardial bridging in children
with HCM.
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REPLY
We thank Drs. McKenna and Alfonso for their comments. Our
report (1) was a review of a large heterogeneous population of
children with hypertrophic cardiomyopathy (HCM). Within this
population, a subgroup of patients with myocardial bridging was
identified. This patient group was further studied and is the focus
of a recent paper (2). The authors’ comments and criticisms appear
to be primarily directed toward that paper.
To clarify, routine angiograms with coronary evaluation were
performed in all patients with symptoms suggestive of myocardial
ischemia (chest pain, syncope or resuscitated sudden death), either
before surgical myectomy or to confirm the diagnosis of HCM
before the routine use of two-dimensional echocardiography. No
medications or maneuvers were used to elicit systolic compression
of the coronary arteries.
We have noted an increased incidence of ventricular tachycardia
in those patients with myocardial bridging demonstrated by
angiography (2). Of note is that, these patients had a significantly
lower blood pressure response to exercise (2), which is thought to
confer a poor prognosis (3) and which occurs secondary to
myocardial ischemia (4). To further support this hypothesis, we
have identified myocardial perfusion abnormalities on thallium
imaging in those patients with myocardial bridging (2). Annual
examination, with 48-h Holter monitoring allowed us to identify
ventricular tachycardia in this high risk group of patients (2).
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As previously stated (2), we believe that coronary angiography
should be part of the diagnostic work-up in those children with
HCM who have clinical indicators of ischemia. We have used
surgical unroofing of the myocardial bridge without complication
(2). All patients undergoing this procedure have demonstrated a
marked change in their clinical outcome with evidence of reversal
of ischemia (2).
Coronary stenting has not been previously used in children with
HCM. Given the authors’ statements concerning high rates of
restenosis, we find it curious that they consider this an attractive
therapeutic strategy.
In summary, children with HCM carry an increased risk of
sudden death. There is evidence to suggest that myocardial
ischemia may be the cause of death in these patients and may occur
from several causes including myocardial bridging (2). Myocardial
bridging is a treatable cause of myocardial ischemia (2,5–7), which
may prove to be a life-saving therapy in these patients.
We agree with the authors in that the association between
myocardial bridging and sudden death in patients with HCM is a
potentially important finding, and as such we believe that this
warrants further study with a multicentered prospective trial.
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Electrical Storm in Patients
With Transvenous
Implantable Cardioverter-Defibrillators
We read with interest the paper by Credner et al. (1) reporting an
incidence of what is called “electrical storm” or clustering of
arrhythmia episodes in patients with implantable cardioverter-
defibrillators (ICDs). This report is similar to other reports
suggesting a 10% incidence of this phenomenon among ICD
recipients. Credner et al. reported precipitating factors for arrhyth-
mia episodes in only 26% of patients, and the patients with
electrical storm had a trend toward having a reduced baroreflex
slope.
Our concern is that reports of arrhythmia clustering, such as the
one from Credner et al. and others, fail to take into account
fundamental observations on the underlying temporal patterns of
arrhythmia recurrence (1,2). The concept of an electrical storm is
intended to designate a marked increase in arrhythmia frequency
that deviates from a baseline frequency. An understanding of this
baseline frequency or pattern is necessary to define electrical storm,
yet is rarely considered. This leaves the definition of electrical
storm completely arbitrary. Previous work has demonstrated that
recurrent ICD detections are nonrandomly distributed over long-
term follow-up in most patients (90%) we have studied (3).
Further analysis of these episodes has shown that there is a distinct
tendency for clustering of arrhythmia recurrences during short
periods. In fact, when considering the interval between consecutive
ICD detections in 31 patients, 55% of these intervals had a value
of #1 h. Thus, two episodes of ventricular arrhythmias within 1 h
is not unusual. Although the concept of electrical storm certainly
has validity for extreme cases, the definition of a storm as $2 to 3
episodes in 24 h, as in previous studies, is overly inclusive (2,3).
More recently, we have demonstrated a fractal pattern to the
distribution of episodes of ventricular tachycardia in patients with
frequent ICD detections (4). This pattern again indicates that
short intervals between tachycardia episodes are much more likely
than long intervals between episodes, and that both the long and
short intervals are part of a single consistent power law distribu-
tion.
These data lead us to believe that the recurrences of ventricular
tachyarrhythmias in patients with an ICD are not random, but
follow a discernable pattern. This tendency toward clustering of
arrhythmia recurrences must be considered when defining electri-
cal storm. Because these events form one distribution, comprising
both the long and short intervals, the criteria for electrical storm
based on a number of events within a brief interval are arbitrary
and do not reflect the true nature of the underlying distribution. A
better index of deviation from the expected pattern would appear
to be the relative number of short to long intervals that are related
to the fractal dimension. Arrhythmia recurrence is likely to depend
on the convergence of several physiologic conditions that may
produce long-lasting (hours to days) changes in the cardiac milieu
that are conducive to the occurrence of ventricular arrhythmias.
Further definition of the temporal pattern of arrhythmia recur-
rences may lead to a better understanding of the complex mech-
anisms of arrhythmia induction. In addition, defining the efficacy
of suppressive antiarrhythmic therapy will benefit from an under-
standing of the pattern of arrhythmia recurrences. The definition
of electrical storm must therefore be derived from an understand-
ing of the “expected pattern” of arrhythmia recurrence. The
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